<DOC>
	<DOCNO>NCT00069524</DOCNO>
	<brief_summary>The primary goal study evaluate short-term safety potential efficacy oyster mushroom ( Pleurotus ostreatus ) treatment hyperlipidemia HIV-infected patient take Kaletra , protease inhibitor ( PI ) commonly use highly active antiretroviral therapy ( HAART ) .</brief_summary>
	<brief_title>Antihyperlipidemic Effects Oyster Mushrooms</brief_title>
	<detailed_description>This single-arm , open-label , 8-week `` proof concept '' pilot study 20 subject determine detectable lipid-lowering effect oyster mushroom patient HIV hyperlipidemia take Kaletra ( ritonavir-containing HAART regimen ) . The study also assess whether concurrent administration oyster mushroom regimens safe , investigate mechanism action whereby oyster mushroom may exert antihyperlipidemic effect .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Hypolipidemic Agents</mesh_term>
	<criteria>Inclusion criterion : Documented HIV infection ( positive ELISA Western Blot measurable plasma HIV RNA ) . Taking Kaletra ( ritonavir/lopinavir ) , ritonavircontaining antiretroviral therapy , least 12 week Elevated nonHDL cholesterol &gt; = 160 mg/dl define National Cholesterol Education Program guideline ( within 30 day enrollment ) AST ALT &lt; 2.5 time upper limit normal ( ULN ) within 30 day study entry . Exclusion criterion : Currently receive antihyperlipidemic treatment ( e.g. , statin , fibrates , bile sequestrants , niacin ) Pregnancy breastfeed Documented history myopathy myalgia HMGCoA reductase inhibitor Documented history rhabdomyolysis Documented diagnosis diabetes mellitus Any condition , judgment investigator , preclude successful participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Highly active antiretroviral therapy ( HAART )</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>Oyster mushroom</keyword>
	<keyword>Non-HDL cholesterol</keyword>
	<keyword>Complementary Therapies</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>